DelsiTech is the world technology leader in advanced biodegradable silica-based controlled release materials. They offer innovative delivery technology for the controlled release of small molecules and biopharmaceuticals, providing products with high commercial potential for unmet clinical and commercial needs. With a focus on parenteral and local administration of drug products, DelsiTech's technology is applicable to a wide range of drug delivery needs.

They specialize in biodegradable silica-based controlled release of small molecule drugs, biopharmaceuticals, and viral vectors. DelsiTech also offers their own drug products that address high unmet clinical and commercial needs. They provide solutions for controlled delivery of gene therapy vectors, viral vaccines, small molecule drugs (including poorly or highly soluble compounds), and complex biomolecules such as proteins, RNA, DNA, and carbohydrates.

DelsiTech collaborates with industry-leading partners, including AstraZeneca, Bayer Pharma, and MedImmune, and participates in key industry events like ChinaBIO Partnering Forum and BIO International Convention. With expertise in drug delivery and formulation, DelsiTech is a trusted and innovative brand in the field